PSC and Autoimmune Liver Disease: Disease Modifiers and Clinical Outcomes
Nov
2026
Description
This session examines factors modifying disease course in PSC and autoimmune hepatitis, including alcohol exposure, statin use, pruritus therapies, and post-transplant recurrence risk.
Presentations
5:00 PM
- 5:15 PM
Convention Center - Bluebird Ballroom 2ABC
Diagnostic Latency and Major Adverse Hepatic Events in Primary Sclerosing Cholangitis: A Multicenter Registry Analysis
Eugenio E Reina | Abstract Presenter
5:15 PM
- 5:30 PM
Convention Center - Bluebird Ballroom 2ABC
ALCOHOL EXPOSURE AND SURVIVAL IN PRIMARY SCLEROSING CHOLANGITIS: A PROPENSITY SCORE-MATCHED COHORT STUDY
Mariana Campuzano, MD | Abstract Presenter
5:30 PM
- 5:45 PM
Convention Center - Bluebird Ballroom 2ABC
Vitamin C reprograms the hepatic immune landscape to alleviate ConA-induced liver injury
JUAN LU, PHD | Abstract Presenter
5:45 PM
- 6:00 PM
Convention Center - Bluebird Ballroom 2ABC
Primary Sclerosing Cholangitis is Associated to the Highest Risk of Recurrence-Related Graft Failure After Liver Transplantation: A Propensity-Matched UNOS Analysis in the Post-DAA Era
Leandro Sierra, MD, | Abstract Presenter
6:00 PM
- 6:15 PM
Convention Center - Bluebird Ballroom 2ABC
Volixibat Improves Pruritus Without Worsening IBD Activity in Patients with PSC: Results from the VISTAS Study IBD Subgroup
Kris V Kowdley, MD, FACP, FACG, AGAF, FAASLD | Abstract Presenter
6:15 PM
- 6:30 PM
Convention Center - Bluebird Ballroom 2ABC
Statin Exposure is Associated with Reduced Hepatic Decompensation and Mortality in Primary Sclerosing Cholangitis
Sameer Rao, MBBS | Abstract Presenter
